Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GMED Globus Medical Inc
- Stocks
- Healthcare
- NYSE: GMED
Price (delayed)
$59.21
Market cap
$8.02B
P/E Ratio
43.54
Dividend/share
N/A
EPS
$1.36
Enterprise value
$7.65B
Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing
Highlights
The company's net income has surged by 179% YoY and by 80% QoQ
The EPS has surged by 131% year-on-year and by 79% since the previous quarter
GMED's equity is up by 4.2% year-on-year but it is down by 2.1% since the previous quarter
GMED's gross margin is up by 2.9% since the previous quarter but it is down by 2.4% year-on-year
Key stats
What are the main financial stats of GMED
Market
Valuations
Earnings
Shares outstanding
135.38M
Market cap
$8.02B
Enterprise value
$7.65B
Price to earnings (P/E)
43.54
Price to book (P/B)
1.99
Price to sales (P/S)
3.23
EV/EBIT
32.74
EV/EBITDA
15.34
EV/Sales
3.05
Revenue
$2.51B
Gross profit
$1.52B
Operating income
$255M
Net income
$185.56M
EBIT
$233.56M
EBITDA
$498.4M
Free cash flow
$522.59M
Per share
Balance sheet
Liquidity
EPS
$1.36
EPS diluted
$1.34
Free cash flow per share
$3.82
Book value per share
$29.72
Revenue per share
$18.36
TBVPS
$18.33
Total assets
$4.71B
Total liabilities
$623.08M
Debt
$92.31M
Equity
$4.09B
Working capital
$1.33B
Debt to equity
0.02
Current ratio
4.45
Quick ratio
2.59
Net debt/EBITDA
-0.74
Margins
Efficiency
Dividend
EBITDA margin
19.9%
Gross margin
60.6%
Net margin
7.4%
Operating margin
10.2%
Return on assets
3.7%
Return on equity
4.6%
Return on invested capital
12.3%
Return on capital employed
5.4%
Return on sales
9.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GMED stock price
How has the Globus Medical stock price performed over time
Intraday
-0.64%
1 week
-0.12%
1 month
-18.47%
1 year
-9.59%
YTD
-28.41%
QTD
-19.11%
Financial performance
How have Globus Medical's revenue and profit performed over time
Revenue
$2.51B
Gross profit
$1.52B
Operating income
$255M
Net income
$185.56M
Gross margin
60.6%
Net margin
7.4%
The company's net income has surged by 179% YoY and by 80% QoQ
The company's operating margin has surged by 127% YoY and by 55% QoQ
The net margin has surged by 111% year-on-year and by 80% since the previous quarter
The operating income has soared by 54% QoQ
Price vs fundamentals
How does GMED's price correlate with its fundamentals
Growth
What is Globus Medical's growth rate over time
Valuation
What is Globus Medical stock price valuation
P/E
43.54
P/B
1.99
P/S
3.23
EV/EBIT
32.74
EV/EBITDA
15.34
EV/Sales
3.05
The EPS has surged by 131% year-on-year and by 79% since the previous quarter
The P/E is 68% less than the last 4 quarters average of 138.0 and 33% less than the 5-year quarterly average of 64.9
The stock's P/B is 38% less than its 5-year quarterly average of 3.2 and 20% less than its last 4 quarters average of 2.5
GMED's equity is up by 4.2% year-on-year but it is down by 2.1% since the previous quarter
GMED's P/S is 45% lower than its 5-year quarterly average of 5.9 and 21% lower than its last 4 quarters average of 4.1
Globus Medical's revenue has increased by 32% YoY
Efficiency
How efficient is Globus Medical business performance
The ROA has soared by 147% year-on-year and by 85% since the previous quarter
Globus Medical's return on equity has surged by 142% YoY and by 77% QoQ
The return on sales has surged by 116% year-on-year and by 86% since the previous quarter
GMED's ROIC has soared by 92% since the previous quarter
Dividends
What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GMED.
Financial health
How did Globus Medical financials performed over time
GMED's quick ratio has surged by 111% year-on-year and by 53% since the previous quarter
Globus Medical's current ratio has surged by 91% YoY and by 75% QoQ
The debt is 98% smaller than the equity
The company's debt to equity has shrunk by 85% QoQ and by 85% YoY
The debt has dropped by 83% since the previous quarter and by 82% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.